🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Monoclonal antibodies can locate tumor cells and either kill the...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2004-07-26
Trial ID
NCT00084799
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as Hu3S193, can block tumor growth i...
Status
Completed
Location
Hospital de Clinicas de Porto Alegre
Start Date
2008-05
Trial ID
NCT00617773
Treatments Being Tested
The humanized monoclonal antibody against Lewis Y antigen (Hu3S193) has bee...
Status
Terminated
Location
Universidade Federal Do Ceará
Start Date
2013-11
Trial ID
NCT01370239
Treatments Being Tested
RATIONALE: Radiolabeled monoclonal antibodies can locate tumor cells and de...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2003-11
Trial ID
NCT00072410
Treatments Being Tested
RATIONALE: Monoclonal antibodies can locate tumor cells and either kill the...
Status
Terminated
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2000-07-12
Trial ID
NCT00006046
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as Hu3S193, can block tumor growth i...
Status
Terminated
Location
Núcleo de Oncologia da Bahia
Start Date
2011-04
Trial ID
NCT01137071
Treatments Being Tested
RATIONALE: Monoclonal antibodies can locate tumor cells and either kill the...
Status
Terminated
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2000-08-02
Trial ID
NCT00006099
Treatments Being Tested